Related Experiment Video

Updated: Aug 6, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Chronic hepatitis B--who should be treated?

Carla S Coffin1, Samuel S Lee

  • 1Liver Unit, Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada.

Medgenmed : Medscape General Medicine
|August 18, 2006
PubMed

Insights

Effective hepatitis B antiviral treatments suppress HBV replication and liver disease remission. This review details current options and criteria for optimal intervention in chronic hepatitis B infection.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis B virus (HBV) causes acute and chronic infections, affecting 350 million globally.
  • Chronic HBV infection increases risk for cirrhosis and hepatocellular carcinoma (HCC).
  • Lifelong monitoring and effective antiviral treatment are crucial for managing HBV-related complications.

Purpose of the Study:

  • To review current antiviral treatment options for chronic hepatitis B infection.
  • To outline criteria for effective intervention with antiviral therapy.
  • To provide guidance for managing HBV carriers and patients with chronic infection.

Main Methods:

  • Literature review of available hepatitis B antiviral therapies.
  • Analysis of treatment goals, including HBV replication suppression and disease remission.
  • Examination of the natural history of hepatitis B and therapeutic decision-making.

Main Results:

  • Significant advancements in chronic HBV treatment over the past decade.
  • Available treatments include interferon alfa, pegylated interferon, and nucleos(t)ide analogs (lamivudine, adefovir dipivoxil, entecavir).
  • Treatment efficacy depends on understanding HBV natural history and patient-specific factors.

Conclusions:

  • Optimizing antiviral therapy requires a comprehensive understanding of HBV infection.
  • Criteria for intervention guide the selection of appropriate treatment strategies.
  • Effective management aims to prevent long-term liver disease complications and improve patient outcomes.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...